Prosperity Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74K | Sell |
19,763
-35
| -0.2% | -$8 | ﹤0.01% | 233 |
|
|
2025
Q1 | $3.9K | Sell |
19,798
-2,072
| -9% | -$408 | ﹤0.01% | 213 |
|
|
2024
Q4 | $11.8K | Sell |
21,870
-2,750
| -11% | -$1.48K | ﹤0.01% | 204 |
|
|
2024
Q3 | $23.4K | Sell |
24,620
-2,000
| -8% | -$1.9K | 0.01% | 189 |
|
|
2024
Q2 | $26K | Hold |
26,620
| – | – | 0.01% | 169 |
|
|
2024
Q1 | $42.1K | Sell |
26,620
-2,000
| -7% | -$3.16K | 0.02% | 151 |
|
|
2023
Q4 | $22.7K | Sell |
28,620
-2,000
| -7% | -$1.59K | 0.01% | 137 |
|
|
2023
Q3 | $23.9K | Hold |
30,620
| – | – | 0.02% | 134 |
|
|
2023
Q2 | $28.3K | Hold |
30,620
| – | – | 0.02% | 142 |
|
|
2023
Q1 | $33.4K | Hold |
30,620
| – | – | 0.03% | 126 |
|
|
2022
Q4 | $44.7K | Buy |
+30,620
| New | +$44.7K | 0.04% | 122 |
|